SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Galirayo who wrote (19999)10/31/2006 9:25:23 AM
From: ACAN  Read Replies (1) of 23958
 
Ray; [GNBT}

Generex Biotechnology Clinical Data to Be Presented at 6th Annual Diabetes Technology Meeting
Tuesday October 31, 8:00 am ET

TORONTO--(MARKET WIRE)--Oct 31, 2006 -- Generex Biotechnology Corporation (NASDAQ:GNBT - News), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it will make two poster presentations of clinical data at the 6th Annual Diabetes Technology Meeting in Atlanta, Georgia, November 2 - 4, 2006. The data relates to Generex Oral-lyn(TM), the Company's proprietary oral insulin spray product designed to replace prandial insulin injections, and to Generex Metformin Gum, a proprietary alternative delivery format for metformin under development by Generex in collaboration with Fertin Pharma A/S.

Allan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext